Longaeva Partners »

Moonlake Immunot shares owned by Longaeva Partners

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.6M 410k 18.64

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
Cormorant Asset Management
Henderson Group
D. E. Shaw & Co
Citadel Advisors
MPM Oncology Impact Management
Weiss Asset Management LP[1
Logos Global Management
Point72 Asset Management
Susquehanna International
Goldman Sachs Group
Two Sigma Investments
Balyasny Asset Management
BlackRock

View all funds holding Moonlake Immunot